Is Avatrombopag a domestic or imported drug and its market comparison?

Avatrombopag (Avatrombopag) is an oral thrombopoietin receptor agonist, mainly used to treat chronic liver disease-related thrombocytopenia and refractory thrombocytopenia. Domestically, avatrombopag has been approved for marketing and is included in medical insurance. Domestic versions are available in two specifications: 20mg10 tablets and 20mg15 tablets. Among them, the latest price of 20mg10 tablets is about 5,000 yuan, and the price of 20mg15 tablets is about 7,000 to 8,000 yuan. The specific medical insurance reimbursement price and self-payment amount need to be determined according to the local hospital pharmacy policy.

The launch of domestically produced avatrombopag provides domestic patients with a safe and reliable treatment option for thrombocytopenia. The ingredients and efficacy of domestic drugs are basically the same as those of international original drugs. At the same time, medical insurance coverage can significantly reduce the financial burden on patients and improve clinical accessibility. When prescribing, doctors will select appropriate specifications and medication plans based on the severity of the patient's condition, weight and platelet level, as well as the medical insurance payment policy.

In overseas markets, there are also generic versions of avatrombopag on the market, such as the Lao version and the Bangladeshi version. The ingredients of these generic drugs are basically the same as those of the original drugs, and the price is relatively low. The latest selling price is around a few hundred yuan. Overseas generic drugs provide a viable option for patients with limited economic conditions, but patients must purchase them through formal channels to ensure drug quality and medication safety and avoid risks caused by informal drug sources.

Generally speaking, domestic avatrombopag is mainly domestically produced original drugs, with prices ranging from more than 5,000 to more than 7,000 yuan, and is included in medical insurance, which improves the convenience of clinical use. Overseas generic drugs are cheaper, but attention must be paid to the formality of the channels. Regardless of the domestic or overseas version, patients should follow the doctor's guidance during use and regularly monitor platelet levels and adverse reactions to ensure efficacy and safety.

Reference materials:https://www.drugs.com/